1. Home
  2. TECH vs EXP Comparison

TECH vs EXP Comparison

Compare TECH & EXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • EXP
  • Stock Information
  • Founded
  • TECH 1976
  • EXP 1963
  • Country
  • TECH United States
  • EXP United States
  • Employees
  • TECH N/A
  • EXP N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • EXP Building Materials
  • Sector
  • TECH Health Care
  • EXP Industrials
  • Exchange
  • TECH Nasdaq
  • EXP Nasdaq
  • Market Cap
  • TECH 7.9B
  • EXP 7.3B
  • IPO Year
  • TECH 1989
  • EXP 1994
  • Fundamental
  • Price
  • TECH $51.61
  • EXP $238.02
  • Analyst Decision
  • TECH Buy
  • EXP Buy
  • Analyst Count
  • TECH 10
  • EXP 11
  • Target Price
  • TECH $73.44
  • EXP $275.45
  • AVG Volume (30 Days)
  • TECH 2.3M
  • EXP 285.9K
  • Earning Date
  • TECH 05-07-2025
  • EXP 05-20-2025
  • Dividend Yield
  • TECH 0.62%
  • EXP 0.42%
  • EPS Growth
  • TECH N/A
  • EXP N/A
  • EPS
  • TECH 0.83
  • EXP 13.93
  • Revenue
  • TECH $1,208,770,000.00
  • EXP $2,267,040,000.00
  • Revenue This Year
  • TECH $8.19
  • EXP $1.58
  • Revenue Next Year
  • TECH $8.61
  • EXP $4.92
  • P/E Ratio
  • TECH $62.17
  • EXP $17.08
  • Revenue Growth
  • TECH 4.72
  • EXP 0.64
  • 52 Week Low
  • TECH $46.44
  • EXP $201.61
  • 52 Week High
  • TECH $85.57
  • EXP $321.93
  • Technical
  • Relative Strength Index (RSI)
  • TECH 49.54
  • EXP 60.41
  • Support Level
  • TECH $46.77
  • EXP $222.36
  • Resistance Level
  • TECH $54.40
  • EXP $241.82
  • Average True Range (ATR)
  • TECH 2.03
  • EXP 6.46
  • MACD
  • TECH 0.70
  • EXP 1.64
  • Stochastic Oscillator
  • TECH 63.43
  • EXP 86.09

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

Share on Social Networks: